Drug Profile
JB 004A
Alternative Names: JB004/ALatest Information Update: 09 Sep 2013
Price :
$50
*
At a glance
- Originator Synphora
- Class Prostaglandins
- Mechanism of Action Prostaglandin agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Meniere's disease; Tinnitus
Most Recent Events
- 09 Sep 2013 No development reported - Phase-II for Meniere's disease in Sweden (unspecified route)
- 09 Sep 2013 No development reported - Phase-II for Tinnitus in Sweden (unspecified route)
- 22 Nov 2006 Phase-II clinical trials in Meniere's disease in Sweden (unspecified route)